Medgend Icon

Ledgend of Medicine







discontinued


Inh FDA Approved Drugs

AFREZZA [Insulin Recombinant Human]
RX
-
12 units/inh (inhalation powder)
4 units/inh (inhalation powder)
8 units/inh (inhalation powder)
MannkindApr 17, 2015
  • Administration of a composition comprising insulin complexed with a diketopiperazine..
  • Administration of a composition comprising insulin complexed with microparticles of a diketopiperazine..
  • Administration of fdkp microparticles comprising insulin..
  • Method of aerosolizing/deagglomerating an insulin dry powder for use in treating diabetes mellitus via oral inhalation using an inhaler with a cartridge containing the insulin dry powder..
  • Method of controlling glycemia in diabetics by administering an initial dose of insulin-fdkp with a meal; determining blood glucose level 1-2 hrs after and administering a supplemental dose of insulin-fdkp if postprandial glucose level is >140 mg/dl.
  • Method of delivering to a patient with diabetes mellitus in a single inhalation, greater than 75% of a dry powder dose comprising insulin and fumaryl diketopiperazine using a high resistance to flow dry powder inhaler..
  • Pulmonary administration of a compisition comprising insulin bound to a diketopiperazine..
  • Pulmonary administration of a composition comprising insulin bound to a complexing agent..
  • Pulmonary administration of an insulin composition comprising fdkp at the beginning of a meal to a patient also being treated with a long-acting insulin..
  • Treatment of a patient having diabetes mellitus with a prandial rapid acting insulin..
  • Treatment of diabetes mellitus with an inhaled insulin to improve glycemic control using a dry powder inhalation system comprising an inhaler, a cartridge and a dry powder medicament comprising insulin in a single inhalation.
  • Treatment of patient having diabetes mellitus via oral inhalation of fdkp microparticles comprising insulin.
  • Use of an inhaler to administer dry powder medicament.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

AGGRASTAT [Tirofiban HydrochlorideC22H36N2O5SClHH2O]
RX
-
eq 12.5mg base/250ml (eq 0.05mg base/ml) (injection injectable)
eq 3.75mg base/15ml (eq 0.25mg base/ml) (injection solution)
eq 5mg base/100ml (eq 0.05mg base/ml) (injection injectable)
MedicureApr 20, 2000
  • A dosing regimen of aggrastat (tirofiban hydrochloride)(25mcg/kg followed by 0.15mcg/kg/min infusion) to reduce the rate of thrombotic coronary events associated with acute coronary syndrome (acs) in patients with non-st elevation acs.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

BREO ELLIPTA [Fluticasone FuroateC27H29F3O6S : Vilanterol TrifenatateC24H33Cl2NO5C20H16O2]
RX
-
0.1mg/inh : eq 0.025mg base/inh (inhalation powder)
0.2mg/inh : eq 0.025mg base/inh (inhalation powder)
Glaxo Grp LtdMay 10, 2013
  • For the long-term, once-daily maintenance treatment of airflow obstruction in patients with copd, including chronic bronchitis and/or emphysema, also to reduce exacerbations of copd in patients with a history of exacerbations.
  • Indicated for long-term, once-daily maintenance treatment of airflow obstruction in pts with copd, including chronic bronchitis and/or emphysema, also to reduce exacerbations of copd in pts with a history of exacerbations.
  • Indicated for the once-daily inhaled treatment for asthma in adults aged 18 years and older.
  • Long-term, once daily maintenance treatment of airflow obstruction in pts with copd, including chronic bronchitis and/or emphysema, also to reduce exacerbations of copd in patients with a history of exacerbations.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

BRILINTA [TicagrelorC23H28F2N6O4S]
RX
-
60mg (oral tablet)
90mg (oral tablet)
Astrazeneca PharmsSep 3, 2015
  • Method of inhibiting platelet aggregation.
  • Reduction of the rate of cardiovascular death, myocardial infarction, and stroke in patients with a history of myocardial infarction.
  • Reduction of the rate of cardiovascular death, myocardial infarction, and stroke in patients with acute coronary syndrome or a history of myocardial infarction.
  • Reduction of the rate of thrombotic events in patients with acute coronary syndrome.
  • Treatment of an arterial thrombotic complication in a patient with coronary artery, cerebrovascular or peripheral vascular disease.
  • Treatment of arterial thrombotic complications selected from the group consisting of unstable angina, thrombotic or embolic stroke, transient ischaemic attacks, peripheral vascular disease and myocardial infarction.
  • Treatment of myocardial infarction and stroke in patients with acute coronary syndrome or a history of myocardial infarction.
  • Treatment of myocardial infarction in patients with acute coronary syndrome or a history of myocardial infarction.
  • Treatment of myocardial infarction.
  • Treatment of post-myocardial infarction.
  • Treatment of stable and unstable angina.
  • Treatment of stroke in patients with acute coronary syndrome or a history of myocardial infarction.
  • Treatment of stroke.
  • Treatment of thrombotic stroke.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

DAKLINZA [Daclatasvir DihydrochlorideC40H50N8O62ClH]
RX
-
eq 30mg base (oral tablet)
eq 60mg base (oral tablet)
eq 90mg base (oral tablet)
Bristol-myers SquibbJul 24, 2015
  • Method of inhibiting hepatitis c virus with daklinza and at least one additional compound having anti-hcv activity.
  • Method of inhibiting hepatitis c virus.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

ESBRIET [PirfenidoneC12H11NO]
RX
-
267mg (oral tablet)
801mg (oral tablet)
Genentech IncJan 11, 2017
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

EVOTAZ [Atazanavir SulfateC38H52N6O7H2O4S : CobicistatC40H53N7O5S2]
RX
-
eq 300mg base : 150mg (oral tablet)
Bristol-myers SquibbJan 29, 2015
  • Method for treating hiv-1 infection.
  • Treatment of hiv infection using a composition containing a pharmacokinetic enhancer that inhibits cytochrome p450 monooxygenase.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

FLOVENT HFA [Fluticasone PropionateC25H31F3O5S]
RX
-
0.044mg/inh (inhalation aerosol, metered)
0.11mg/inh (inhalation aerosol, metered)
0.22mg/inh (inhalation aerosol, metered)
Glaxo Grp LtdMay 14, 2004
  • Method of treating a condition capable of treatment by inhalation, e.g. asthma, comprising administration of a formulation claimed in us patent no. 6743413.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

GANIRELIX ACETATE [Ganirelix AcetateC80H113ClN18O132C2H4O2]
RX
-
eq 250mcg base/0.5ml (injection injectable)
Organon Usa IncJul 29, 1999
  • Inhibition of premature lh surges in women undergoing controlled ovarian hyperstimulation with fsh.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

GENVOYA [CobicistatC40H53N7O5S2 : ElvitegravirC23H23ClFNO5 : EmtricitabineC8H10FN3O3S : Tenofovir Alafenamide Fumarate2C21H29N6O5PC4H4O4]
RX
-
150mg : 150mg : 200mg : eq 10mg base (oral tablet)
Gilead Sciences IncNov 5, 2015
  • Treatment of hiv infection using a composition containing a pharmacokinetic enhancer that inhibits cytochrome p450 monooxygenase.
  • Treatment of hiv infection.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

HETLIOZ [TasimelteonC15H19NO2]
RX
-
20mg (oral capsule)
Vanda Pharms IncJan 31, 2014
  • Treatment of non-24-hour sleep-wake disorder by avoiding the use of tasimelteon in combination with a strong cyp1a2 inhibitor.
  • Treatment of non-24-hour sleep-wake disorder by avoiding the use of tasimelteon in combination with fluvoxamine.
  • Treatment of non-24-hour sleep-wake disorder.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

IBRANCE [PalbociclibC24H29N7O2]
RX
-
100mg (oral capsule)
125mg (oral capsule)
75mg (oral capsule)
Pfizer IncFeb 3, 2015
  • Treating hr-pos., her2-neg. advanced or metastatic breast cancer with palbociclib in combo with an aromatase inhibitor as initial endocrine based therapy in postmenopausal women or fulvestrant in women with disease progression after endocrine therapy.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

INOMAX [Nitric OxideNO]
RX
-
800ppm (inhalation gas)
Mallinckrodt HospDec 23, 1999
  • A method of providing a predetermined concentration of nitric oxide to a patient.
  • A method of providing nitric oxide therapy to a patient by compensating long-term sensitivity drift of electrochemical gas sensors used in systems for delivering therapeutic nitric oxide to a patient.
  • A method of providing nitric oxide therapy to a patient by verifying gas information of nitric oxide prior to delivery to patient.
  • A method of providing nitric oxide therapy to a patient.
  • A method of purging a nitric oxide delivery system.
  • A method of reducing the risk of pulmonary edema in patients in need of treatment with inhaled nitric oxide.
  • A method of treating hypoxic respiratory failure by verifying gas information of nitric oxide prior to delivery to patient.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

INSPRA [EplerenoneC24H30O6]
RX
-
25mg (oral tablet)
50mg (oral tablet)
Gd Searle LlcSep 27, 2002
  • Treatment of conditions for which an aldosterone receptor blocker is indicated, such as hypertension, heart failure, and post-myocardial infarction.
  • Treatment of conditions related to hyperaldosteronism such as hypertension and cardiac insufficiency, with eplerenone.
  • Treatment of hypertension.
  • Use of eplerenone in combination with an angiotensin converting enzyme (ace) inhibitor (and optionally a diuretic) for treating congestive heart failure and hypertension.
  • Use of eplerenone in combination with an angiotensin converting enzyme (ace) inhibitor for treating hypertension.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

INTELENCE [EtravirineC20H15BrN6O]
RX
-
100mg (oral tablet)
200mg (oral tablet)
25mg (oral tablet)
Janssen R And DJan 18, 2008
  • Combo w/ other antiretrovirals for tx of hiv-1 in antiretroviral tx-experienced pt 6 years up, who have evidence of viral replication and hiv-1 strains resistant to non-nucleoside reverse transcriptase inhibitor and other antiretrovirals.
  • In combination with other antiretroviral agents for the treatment of hiv-1 infection in treatment-experienced adult patients, who have evidence of viral replication and hiv-1 strains resistant to an nnrti and other antiretroviral agents.
  • Treatment of hiv infection in combination with one or more additional hiv antiviral agents.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

ISENTRESS [Raltegravir PotassiumC20H20FN6O5K]
RX
-
eq 100mg base (oral tablet, chewable)
eq 100mg base/packet (oral powder)
eq 25mg base (oral tablet, chewable)
eq 400mg base (oral tablet)
Merck Sharp DohmeDec 21, 2011
  • Treatment of hiv infection.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

ISENTRESS HD [Raltegravir PotassiumC20H20FN6O5K]
RX
-
eq 600mg base (oral tablet)
Merck Sharp DohmeMay 26, 2017
  • Integrase inhibition for the treatment of hiv infection.
  • Treatment of hiv infection.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

ISONIAZID [IsoniazidC6H7N3O]
RX
-
100mg (oral tablet)
100mg/ml (injection injectable)
300mg (oral tablet)
50mg/5ml (oral syrup)
BarrApproved Prior To Jan 1, 1982
MikartJun 26, 1997
SandozApproved Prior To Jan 1, 1982
Thepharmanetwork LlcOct 29, 2014
Sandoz IncJul 5, 2005
Cmp Pharma IncNov 10, 1983
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

JAKAFI [Ruxolitinib PhosphateC17H18N6H3O4P]
RX
-
eq 10mg base (oral tablet)
eq 15mg base (oral tablet)
eq 20mg base (oral tablet)
eq 25mg base (oral tablet)
eq 5mg base (oral tablet)
Incyte CorpNov 16, 2011
  • For the treatment of intermediate or high-risk myelofibrosis.
  • For the treatment of polycythemia vera.
  • Use of ruxolitinib (jakafi) for blocking signal transduction of janus associated kinases (jaks) jak1 and/or jak2.
  • Use of ruxolitinib (jakafi) for inhibiting janus associated kinases (jaks) jak1 and/or jak2..
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

JANUMET [Metformin HydrochlorideC4H11N5ClH : Sitagliptin PhosphateC16H15F6N5OH2OH3O4P]
RX
-
1gm : eq 50mg base (oral tablet)
500mg : eq 50mg base (oral tablet)
Merck Sharp DohmeMar 30, 2007
  • Improvement of glycemic control in adults with type 2 diabetes mellitus.
  • Method of treating type 2 diabetes mellitus by administering a dipeptidyl peptidase-4 inhibitor in combination with insulin.
  • Method of treating type 2 diabetes mellitus by administering a dipeptidyl peptidase-4 inhibitor in combination with metformin and a ppar-gamma agonist.
  • Method of treating type 2 diabetes mellitus by administering a dipeptidyl peptidase-iv inhibitor in combination with metformin.
  • Method of treating type 2 diabetes mellitus by administering a dipeptidyl peptidase-iv inhibitor.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

JANUVIA [Sitagliptin PhosphateC16H15F6N5OH2OH3O4P]
RX
-
eq 100mg base (oral tablet)
eq 25mg base (oral tablet)
eq 50mg base (oral tablet)
Merck Sharp DohmeOct 16, 2006
  • Improvement of glycemic control in adults with type 2 diabetes mellitus in combination with metformin and/or a ppar-gamma agonist and/or sulfonylurea and/or insulin.
  • Improvement of glycemic control in adults with type 2 diabetes mellitus in combination with metformin..
  • Improvement of glycemic control in adults with type 2 diabetes mellitus.
  • Method of treating type 2 diabetes mellitus by administering a dipeptidyl peptidase-4 inhibitor in combination with insulin.
  • Method of treating type 2 diabetes mellitus by administering a dipeptidyl peptidase-4 inhibitor in combination with metformin and a ppar-gamma agonist.
  • Method of treating type 2 diabetes mellitus by administering a dipeptidyl peptidase-iv inhibitor in combination with a ppar-gamma agonist.
  • Method of treating type 2 diabetes mellitus by administering a dipeptidyl peptidase-iv inhibitor in combination with metformin and/or a sulfonylurea.
  • Method of treating type 2 diabetes mellitus by administering a dipeptidyl peptidase-iv inhibitor.
  • Method of treating type 2 diabetes mellitus by administering a dipeptidyl peptidaste-iv inhibitor.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

JENTADUETO [LinagliptinC25H28N8O2 : Metformin HydrochlorideC4H11N5ClH]
RX
-
2.5mg : 1gm (oral tablet)
2.5mg : 500mg (oral tablet)
2.5mg : 850mg (oral tablet)
Boehringer IngelheimJan 30, 2012
  • Method of treating type 2 diabetes mellitus by administering a dipeptidyl peptidase-4 inhibitor in combination with metformin.
  • Method of treating type 2 diabetes mellitus by administering a dipeptidyl peptidase-iv inhibitor in combination with metformin and/or a sulfonylurea.
  • Method of treating type 2 diabetes mellitus by administering a dipeptidyl peptidase-iv inhibitor.
  • Method of treating type 2 diabetes mellitus by administering linagliptin in combination with metformin.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

JENTADUETO XR [LinagliptinC25H28N8O2 : Metformin HydrochlorideC4H11N5ClH]
RX
-
2.5mg : 1gm (oral tablet, extended release)
Boehringer IngelheimMay 27, 2016
  • Method of treating type 2 diabetes in patients who have not been previously treated with an antihyperglycemic agent by administering linagliptin in combination with metformin.
  • Method of treating type 2 diabetes in patients with insufficient glycemic control despite therapy with one or more conventional antihyperglycemic agents by administering linagliptin in combination with metformin.
  • Method of treating type 2 diabetes mellitus by administering a dipeptidyl peptidase-iv inhibitor in combination with metformin and, optionally, a sulfonylurea.
  • Method of treating type 2 diabetes mellitus by administering a dipeptidyl peptidase-iv inhibitor in combination with metformin.
  • Method of treating type 2 diabetes mellitus by administering a dipeptidyl peptidase-iv inhibitor.
  • Method of treating type 2 diabetes mellitus by administering linagliptin in combination with metformin.
  • Method of treating type 2 diabetes.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

KAZANO [Alogliptin BenzoateC18H21N5O2C7H6O2 : Metformin HydrochlorideC4H11N5ClH]
RX
-
eq 12.5mg base : 1gm (oral tablet)
eq 12.5mg base : 500mg (oral tablet)
Takeda Pharms UsaJan 25, 2013
  • Method of treating diabetes comprising administering a compound such as alogliptin.
  • Method of treating diabetes comprising administering alogliptin.
  • Methods of lowering elevated post prandial blood glucose levels comprising administering a dipeptidyl peptidase inhibitor.
  • Methods of modifying glucose metabolism and treating diabetes comprising administering a dipeptidyl peptidase inhibitor and one or more other therapeutic agents such as metformin.
  • Methods of reducing the side effects of active components administered to a diabetic patient comprising administering an insulin sensitivity enhancer such as pioglitazone in combination with an insulin secretion enhancer.
  • Methods of treating diabetes comprising administering a dipeptidyl peptidase inhibitor and metformin.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

KENGREAL [CangrelorC17H25Cl2F3N5O12P3S2]
RX
-
50mg/vial (iv (infusion) powder)
Chiesi Usa IncJun 22, 2015
  • Method of treating, reducing the incidence of, or preventing an ischemic event in a patient undergoing pci by administering intravenously 30 ug/kg bolus before pci and continuous infusion of 4 ug/kg/min for at least 2 hours or the duration of the pci.
  • P2y12 platelet inhibitor for use as adjunct to percutaneous coronary intervention to reduce risk of various diseases/conditions in patients not treated with a p2y12 platelet inhibitor and not given a glycoprotein iib/iiia inhibitor.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

KISQALI [Ribociclib SuccinateC23H30N8OC4H6O4]
RX
-
eq 200mg base (oral tablet)
Novartis Pharms CorpMar 13, 2017
  • In combination with an aromatase inhibitor as initial endocrine-based therapy for treatment of postmenopausal women with hormone receptor (hr)-positive, human epidermal growth factor receptor 2 (her-2)-negative advanced or metastatic breast cancer.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

KISQALI FEMARA CO-PACK (COPACKAGED) [LetrozoleC17H11N5 : Ribociclib SuccinateC23H30N8OC4H6O4]
RX
-
2.5mg,n/a : n/a,eq 200mg base (oral tablet, tablet)
Novartis Pharms CorpMay 4, 2017
  • In combination with an aromatase inhibitor as initial endocrine-based therapy for treatment of postmenopausal women with hormone receptor (hr)-positive, human epidermal growth factor receptor 2 (her-2)-negative advanced or metastatic breast cancer.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

LANIAZID [IsoniazidC6H7N3O]
RX
-
300mg (oral tablet)
LannettJun 13, 1988
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

LYNPARZA [OlaparibC24H23FN4O3]
RX
-
50mg (oral capsule)
Astrazeneca PharmsDec 19, 2014
  • Treatment of brca mutated ovarian cancer using parp inhibitor.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

NESINA [Alogliptin BenzoateC18H21N5O2C7H6O2]
RX
-
eq 12.5mg base (oral tablet)
eq 25mg base (oral tablet)
eq 6.25mg base (oral tablet)
Takeda Pharms UsaJan 25, 2013
  • Method of treating diabetes comprising administering a compound such as alogliptin.
  • Method of treating diabetes comprising administering alogliptin.
  • Methods of lowering elevated post prandial blood glucose levels comprising administering a dipeptidyl peptidase inhibitor.
  • Methods of modifying glucose metabolism and treating diabetes comprising administering a dipeptidyl peptidase inhibitor and one or more other therapeutic agents such as metformin.
  • Methods of reducing the side effects of active components administered to a diabetic patient comprising administering an insulin sensitivity enhancer such as pioglitazone in combination with an insulin secretion enhancer.
  • Methods of treating diabetes comprising administering a dipeptidyl peptidase inhibitor and metformin.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

NIASPAN [NiacinC6H5NO2]
RX
-
1gm (oral tablet, extended release)
500mg (oral tablet, extended release)
750mg (oral tablet, extended release)
AbbvieJul 28, 1997
  • A method of reducing the capacity of extended release nicotinic acid to provoke a flushing reaction by pretreating an individual with a flush inhibiting agent prior to the administration of the extended release nicotinic acid.
  • Method of treating hyperlipidemia with nicotinic acid by dosing once per day in the evening or at night.
  • Reduction in elevated tc and ldl-c by dosing once per day in the evening or at night, with pretreatment with a flush inhibitin agent such as aspirin.
  • Reduction in elevated tc and ldl-c by dosing once per day in the evening or at night.
  • Reduction in risk of recurrent nonfatal myocardial infarction by dosing once per day in the evening or a t night, with pretreatment with a flush inhibitin agent such as aspirin.
  • Reduction in risk of recurrent nonfatal myocardial infarction by dosing once per day in the evening or at night.
  • Reduction in tg by dosing once per day in the evening or at night, with pretreatment with a flush inhibiting agent such as aspirin.
  • Reduction in tg by dosing once per day in the evening or at night.
  • Treatment of primary and mixed dyslipidemia by dosing once per day in the evening or at night, with pretreatment with a flush inhibiting agent such as aspirin.
  • Treatment of primary and mixed dyslipidemia by dosing once per day in the evening or at night.
efficacy
3.0  (1)
side effects
0.0  (0)
danger
0.0  (0)

UNK

OPSUMIT [MacitentanC19H20Br2N6O4S]
RX
-
10mg (oral tablet)
Actelion Pharms LtdOct 18, 2013
  • Method of treating pulmonary arterial hypertension by administering a pharmaceutical composition comprising macitentan and a polysorbate, wherein the polysorbate represents 0.1 to 3% of the weight of said pharmaceutical composition.
  • Method of treating pulmonary arterial hypertension by administering a pharmaceutical composition comprising macitentan and a polysorbate, wherin the polysorbate represents 0.1 to 1% of the weight of said pharmaceutical composition.
  • Method of treating pulmonary hypertension comprising administering macitentan in combination with a compound having phosphodiesterase-5 inhibitory properties.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

OSENI [Alogliptin BenzoateC18H21N5O2C7H6O2 : Pioglitazone HydrochlorideC19H20N2O3SClH]
RX
-
eq 12.5mg base : eq 15mg base (oral tablet)
eq 12.5mg base : eq 30mg base (oral tablet)
eq 12.5mg base : eq 45mg base (oral tablet)
eq 25mg base : eq 15mg base (oral tablet)
eq 25mg base : eq 30mg base (oral tablet)
eq 25mg base : eq 45mg base (oral tablet)
Takeda Pharms UsaJan 25, 2013
  • Method of treating diabetes comprising administering a compound such as alogliptin.
  • Method of treating diabetes comprising administering alogliptin.
  • Methods of lowering elevated post prandial blood glucose levels comprising administering a dipeptidyl peptidase inhibitor.
  • Methods of modifying glucose metabolism and treating diabetes comprising administering a dipeptidyl peptidase inhibitor and one or more other therapeutic agents such as metformin.
  • Methods of reducing the side effects of active components administered to a diabetic patient comprising administering an insulin sensitivity enhancer such as pioglitazone in combination with an insulin secretion enhancer.
  • Methods of treating diabetes comprising administering an insulin sensitivity enhancer such as pioglitazone in combination with an insulin secretion enhancer.
  • Methods of treating diabetes comprising administering a dipeptidyl peptidase inhibitor and metformin.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

OTEZLA [Apremilast]
RX
-
10mg (oral tablet)
20mg (oral tablet)
30mg (oral tablet)
Celgene CorpMar 21, 2014
  • Use of otezla (apremilast) for inhibiting pde4.
  • Use of otezla (apremilast) for the treatment of psoriasis.
  • Use of otezla (apremilast) for the treatment of psoriatic arthritis.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

PICATO [Ingenol MebutateC25H34O6]
RX
-
0.015% (topical gel)
0.05% (topical gel)
Leo LabsJan 23, 2012
  • To inhibit the proliferative activity of neoplastic cells.
  • To stimulate the immune system to induce t cell proliferation.
  • Treatment of actinic keratosis.
  • Use of ingenol mebutate to treat actinic keratosis.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

POMALYST [PomalidomideC13H11N3O4]
RX
-
1mg (oral capsule)
2mg (oral capsule)
3mg (oral capsule)
4mg (oral capsule)
CelgeneFeb 8, 2013
  • Use of pomalidomide for the treatment of multiple myeloma.
  • Use of pomalidomide to inhibit the secretion of pro-inflammation cytokines, including tumor necrosis factor alpha.
  • Use of pomalidomide while preventing the exposure of a fetus or other contraindicated individual to pomalidomide.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

REVLIMID [LenalidomideC13H13N3O3]
RX
-
10mg (oral capsule)
15mg (oral capsule)
2.5mg (oral capsule)
20mg (oral capsule)
25mg (oral capsule)
CelgeneDec 27, 2005
  • Treatment of male patient having a disease or condition responsive to a teratogenic drug.
  • Use of revlimid (lenalidomide) for the treatment of mantle cell lymphoma (mcl).
  • Use of revlimid (lenalidomide) for the treatment of multiple myeloma and transfusion-dependent anemia in myelodysplastic syndromes (mds).
  • Use of revlimid (lenalidomide) for the treatment of multiple myeloma.
  • Use of revlimid (lenalidomide) for the treatment of transfusion-dependent anemia in myelodysplastic syndromes (mds).
  • Use of revlimid (lenalidomide) to inhibit the secretion of pro-inflammatory cytokines, including tumor necrosis factor alpha.
  • Use of revlimid (lenalidomide) while preventing the exposure of a fetus or other contraindicated individual to revlimid (lenalidomide).
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

SPINRAZA [Nusinersen Sodium]
RX
-
12mg/5ml (2.4mg/ml) (intrathecal solution)
Biogen IdecDec 23, 2016
  • Treatment of infantile-onset spinal muscular atrophy.
  • Treatment of spinal muscular atrophy by increasing exon-7 inclusion in smn2 mrna.
  • Treatment of spinal muscular atrophy by inhibiting an smn2 pre-mrna intronic splicing silencer site.
  • Treatment of spinal muscular atrophy.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

SPIRIVA [Tiotropium Bromide]
RX
-
eq 0.018mg base/inh (inhalation powder)
Boehringer IngelheimJan 30, 2004
  • Administration of an inhalable powder comprising tiotropium via device.
  • For the long-term, once-daily, maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (copd), including chronic bronchitis and emphysema.
  • Treatment of chronic obstructive pulmonary disease.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

STIVARGA [RegorafenibC21H15ClF4N4O3]
RX
-
40mg (oral tablet)
Bayer HlthcareSep 27, 2012
  • Treatment of patients with gastrointestinal stromal tumor (gist), including but not limited to patients previously treated with imatinib and patients with gist having resistance to a kit tyrosine kinase inhibitor.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

STRIBILD [CobicistatC40H53N7O5S2 : ElvitegravirC23H23ClFNO5 : EmtricitabineC8H10FN3O3S : Tenofovir Disoproxil FumarateC19H30N5O10PC4H4O4]
RX
-
150mg : 150mg : 200mg : 300mg (oral tablet)
Gilead Sciences IncAug 27, 2012
  • Treatment of hiv infection using a composition containing a pharmacokinetic enhancer that inhibits cytochrome p450 monooxygenase.
  • Treatment of hiv infection.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

SYNRIBO [Omacetaxine MepesuccinateC29H39NO9]
RX
-
3.5mg/vial (subcutaneous powder)
Teva Pharms IntlOct 26, 2012
  • Treatment of leukemia.
  • Treatment of patients with tyrosine kinase inhibitor (tki) resistant or intolerant chronic myeloid/myelogenous leukemia (cml).
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

TRADJENTA [LinagliptinC25H28N8O2]
RX
-
5mg (oral tablet)
Boehringer IngelheimMay 2, 2011
  • Method of treating type 2 diabetes mellitus by administering a dipeptidyl peptidase-4 inhibitor in combination with pioglitazone.
  • Method of treating type 2 diabetes mellitus by administering a dipeptidyl peptidase-4 inhibitor in combination with sulfonlyurea.
  • Method of treating type 2 diabetes mellitus by administering a dipeptidyl peptidase-iv inhibitor in combination with metformin and/or a sulfonylurea.
  • Method of treating type 2 diabetes mellitus by administering a dipeptidyl peptidaste-iv inhibitor.
  • Method of treating type 2 diabetes mellitus by administering linagliptin in combination with insulin (with or without metformin and/or pioglitazone).
  • Method of treating type 2 diabetes mellitus by administering linagliptin in combination with metformin.
  • Method of treating type 2 diabetes mellitus by administering linagliptin.
  • Method of treating type 2 diabetes mellitus in patients with severe chronic renal impairment and for whom metformin therapy is inappropriate by administering linagliptin.
  • Method of treating type 2 diabetes mellitus in patients with severe chronic renal impairment and who are ineligible for metformin therapy by administering linagliptin.
  • Treatment of type 2 diabetes mellitus.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

TYBOST [CobicistatC40H53N7O5S2]
RX
-
150mg (oral tablet)
Gilead Sciences IncSep 24, 2014
  • Treatment of hiv infection using a composition containing a pharmacokinetic enhancer that inhibits cytochrome p450 monooxygenase.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

TYVASO [TreprostinilC23H34O5]
RX
-
0.6mg/ml (inhalation solution)
United TherapJul 30, 2009
  • Method of treating pulmonary hypertension by administering treprostinil or a salt thereof by inhalation using a device.
  • Treatment of pulmonary hypertension by inhalation.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

VIEKIRA PAK (COPACKAGED) [Dasabuvir Sodium : OmbitasvirC50H67N7O8 : ParitaprevirC40H43N7O7S : RitonavirC37H48N6O5S2]
RX
-
eq 250mg base,n/a,n/a,n/a : n/a,12.5mg,75mg,50mg (oral tablet, tablet)
Abbvie IncDec 19, 2014
  • Treatment of hcv infection using dasabuvir.
  • Treatment of hcv infection using ombitasvir.
  • Treatment of hcv infection using paritaprevir, ombitasvir, ritonavir, and dasabuvir with ribavirin..
  • Treatment of hcv infection using paritaprevir, ombitasvir, ritonavir, and dasabuvir, without ribavirin.
  • Treatment of hcv infection using paritaprevir.
  • Use of dasabuvir to inhibit viral replication for the treatment of hcv infection..
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

VIEKIRA XR [Dasabuvir Sodium : OmbitasvirC50H67N7O8 : ParitaprevirC40H43N7O7S : RitonavirC37H48N6O5S2]
RX
-
eq 200mg base : 8.33mg : 50mg : 33.33mg (oral tablet, extended release)
Abbvie IncJul 22, 2016
  • Treatment of hcv infection using dasabuvir.
  • Treatment of hcv infection using dasabuvir/ombitasvir/paritaprevir/ritonavir fixed dose combination.
  • Treatment of hcv infection using ombitasvir.
  • Treatment of hcv infection using paritaprevir, ombitasvir, ritonavir, and dasabuvir with ribavirin..
  • Treatment of hcv infection using paritaprevir, ombitasvir, ritonavir, and dasabuvir, without ribavirin.
  • Treatment of hcv infection using paritaprevir.
  • Use of dasabuvir to inhibit viral replication for the treatment of hcv infection..
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

ZYDELIG [IdelalisibC22H18FN7O]
RX
-
100mg (oral tablet)
150mg (oral tablet)
Gilead Sciences IncJul 23, 2014
  • A method of disrupting leukocyte function, including as an inhibitor of pi3kdelta kinase.
  • For the treatment of patients with cll, fl, or sll.
  • For the treatment of patients with relapsed chronic lymphocytic leukemia.
  • For the treatment of patients with relapsed follicular b-cell non-hodgkin lymphoma or [relapsed] small lymphocytic lymphoma.
  • In combination with rituximab, for the treatment of patients with relapsed chronic lymphocytic leukemia (cll).
  • Inhibition on pi3k kinase.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.


WARNING: All medicines, drugs, plants, chemicals or medicial precedures below are for reference only. Many of these treatments may be harmful and possibly fatal. Do not consume any plant, chemical, drug or otherwise without first consulting a licensed physician that practices medine in the appropriate field. The owner of this website will not be held liable for any injuries and deaths cause by following any home remedies. We have no control of what is posted.

Home Remedies for Inh

BLOCKED SINUSES
   Apply a few drops into an ultrasonic humidifier or into warm water and inhale the vapors. Frankincense essential oil is good for relaxing the chest and nasal airways.LoisaAllcott | July 19th, 2018
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

ERECTILE DYSFUNCTION - ED [impotence]
   The most popular pharmaceutical remedy for ED are Cialis (tadalafil) or Viagra (sildenafil). Both are phosphodiesterase-5 (PDE5) inhibitors for treating impotence. Other drugs to treat erectile dysfunction (ED) include Stendra, Staxyn and Levitra.

Erectile dysfunction can be a symptom of a serious health problem. Consult a physician if you are experiencing impotence over a long period.
Mechanism - phosphodiesterase-5 PDE5 inhibitors
MaryFreeman | May 15th, 2020
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

SORE THROAT [Pharyngitis]
   Red root (Ceanothus americanus) contains ceanothic acid and ceanothetric acid which have been claimed to inhibit Streptococcus bacteria growth in tincture form. To make Red root tea, heat 1 pint of water just below boiling and add 1 ounce of red root. Heat for 20 minutes. Let cool. Gargle with 1 tablespoon, then swallow. Repeat for a total of 4 times a day.
Mechanism - ceanothine A-E, pandamine, zizyphine, scutianine, adouetines
GuydeMaupassant | August 11th, 2020
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK


WARNING: All medicines, drugs, plants, chemicals or medicial precedures below are for historical reference only. Many of these treatments are now known to be harmful and possibly fatal. Do not consume any plant, chemical, drug or otherwise without first consulting a licensed physician that practices medine in the appropriate field.

Felter's Materia Medica on Inh

ABIES (Tsuga canadensis)TSCA
   The bark and prepared resinous exudate of Tsuga canadensis, Carriére (Abies canadensis, Michaux; Pinus canadensis, Linné). (Nat. Ord.... / ...and ulcerations of the nasal fossae and throat. The oil dropped upon boiling water is a timehonored inhalation for croup. It has also been used to advantage in some forms of eczema, particularly the w... / ...be used where there is excessive secretion of mucus and the cough is largely precipitated by a feeble and relaxed state of the uvula and fauces. 2

ACONITUM NEPALLUS
   The dried tuberous root of Aconitum Napellus, Linné (Nat. Ord. Ranunculaceae). Mountains of Europe and Asia, and northwestern North America.... / ...ntense cutaneous itching. Both are extremely irritating to the nasal and ocular membranes, and when inhaled may give rise to a peculiar local sense of icy-coldness. Administered internally in small do... / ...approaching from the extremities to the body. Excessive sweating comes on, rapidly lowering the body temperature, dimness of vision, 2

ALLIUM CEPA
   The fresh bulb of Allium Cepa, Linné (Nat. Ord. Liliaceae). Common in cultivation everywhere. Common Name: Onion. Principal Constituent.—A... / ...ause nausea and disorder digestion. It, together with the onion poultice, are among the good things inherited from domestic medication, and might well be considered in preference to less safe and less... / ...given with an equal quantity of tincture of Xanthium Strumarium. 2

CAMPHORA
   ...els flatus. Large doses may induce vomiting. Camphor is readily absorbed, both from application and inhalation. It is largely changed in the body and is eliminated in the urine as campho-glycuronic ac......, and inflammatory swellings. An ethereal tincture of camphor is said to give relief in erysipelas. Inhaling the spirit, or camphor dropped into hot water, gives relief in nervous headache, and often ...2

DIGITALIS
   ...e nervous system, and then it lessens reflex activity through stimulation of Setschenow's center of inhibition in the medulla, and is followed by depression of the spinal cord and motor nerve trunks a......nimals; apparently they do not take place in man. Therapeutic doses, however, stimulate the cardiac inhibitory and vasomotor centers of the medulla. Digitalis, in moderate doses, has little or no effe...2

EUCALYPTUSEUAN12
   The leaves of Eucalyptus Globulus, Labillardiere. Collected from the older parts of the tree. (Nat. Ord. Myrtaceae.) A native tree of Australia;... / ...unds, gonorrhoeal discharges, ozoena, septicemia, and gangrene; all with free but fetid discharges. Inhalations of them are especially useful in pulmonary gangrene. Internal. Eucalyptus is a fine stim... / ...Used according to indications as given above, eucalyptus is a very satisfactory and pleasant medicine. It is best given in syrup or glycerin.2

IPECACUANHA (Cephaelis Ipecacuanha).
   The root of (1) Cephaelis Ipecacuanha (Brotero), A. Richard, or of (2) Cephaelis acuminata, Karsten (Nat. Ord. Rubiaceae). Brazil and other parts... / ...ion it excites irritation, and produces vesicular and pustular eruptions and sometimes ulcers. When inhaled it causes heat and violent sneezing. In susceptible individuals the powdered drug excites pr... / ...sight of as a remedy for active hemorrhage. Of course, it operates best where the quantity of blood lost is small. We have seen most excellent r2

LOBELIALOBEL
   The leaves, tops, and seeds of Lobelia inflata, Linné (Nat. Ord. Lobeliaceae). Abundant in the United States. Dose, 1 to 60 grains. Common... / ...on may result. In large doses a state of near-collapse is induced. Small doses act upon the cardiac inhibitory apparatus, slowing the heart action, but this is followed by a more or less accelerated p...2

RELATED MEDICINE
   Tobacco (Nicotiana Tabacum, Linné) and Nicotine. Tobacco was once used to a considerable extent upon painful inflammatory swellings and to relax strangulated... / ...tine, hence this preparation must be used with great caution, and care should be had in handling or inhaling it. A combination of tobacco alkaloids is an ingredient of Libradol.2

MANGIFERA
   The inner bark of the root and tree of Mangifera indica, Linné (Nat. Ord. Anacardiaceae). A native East Indian fruit tree; naturalized in the... / ...be added to two ounces of water. Internal. Owing probably to its tannic acid, and somewhat to other inherent principles, mangifera is a useful drug in relaxation of mucous tissues, associated with cat... / ...and digestion, and apparently is non- constipating. When not contraindicated syrup is a fairly good vehicle for mangifera in throat affections.2

MENTHOL
   Menthol. A secondary alcohol obtained from the oil of Mentha piperita, Linné, or from other oils of mints. It should be kept in well-stoppered... / ...ble in water. It gives a feeling of warmth when tasted, followed by a sensation of cold when air is inhaled or water is drunk. Dose, 1/8 to 2 grains. Specific Indications.—Pruritus; nausea and vomiti... / ...is sometimes of value in hiccough. It should not be used in large doses internally because of the profound nervous disturbances it may occasion.2

OLEUM TEREBINTHINAE RECTIFICATUM
   Rectified Oil of Turpentine, Rectified Turpentine Oil. Description.—A thin colorless liquid corresponding to the properties described under Oleum... / ...creased. Being quickly absorbed it appears in the urine almost immediately after being swallowed or inhaled, imparting to that excretion the characteristic odor of violets. The vapor is irritating to ...2

PHYTOLACCA
   The recently dried root and fruit of Phytolacca americana, Linné (Nat. Ord. Phytolaccaceae). North America, along roadsides and fences, and in... / ...tice of the root, it produces an erythematous, sometimes pustular, eruption. The powdered root when inhaled is very irritating to the respiratory passages, and often produces a severe coryza, with hea...2

PILOCARPUSPILOC
   The dried leaflets of (1) Pilocarpus Jaborandi, Holmes; or (2) Pilocarpus microphyllus, Stapf (Nat. Ord. Rutaceae). Brazil and Paraguay. Dose, 20... / ...ge doses they are cardiac depressants, probably affecting the heart muscle and to some degree vagal inhibition. The extent to which the vaso-motor system participates in first causing increased and th... / ...bronchial and lachrimal flow. The saliva contains an abundance of ptyalin and salts and readily converts starch into sugar. At times the mucous 2

PODOPHYLLUM
   The dried rhizome and roots of Podophyllum peltatum, Linné (Nat. Ord. Berberidaceae). Rich woods and thickets of North America. Dose, 5 to 30... / ...ly podophyllum and its resin cause irritation and suppuration of the skin and subcutaneous tissues; inhaled they provoke sneezing and violent coryza, and drug workers handling either are sometimes aff...2


WARNING: All medicines, drugs, plants, chemicals or medicial precedures below are for historical reference only. Many of these treatments are now known to be harmful and possibly fatal. Do not consume any plant, chemical, drug or otherwise without first consulting a licensed physician that practices medine in the appropriate field.

Physician's Materia Medica on Inh

ACID SALICYLIC and SALICYLATES
   a. Salicyi iC Acid . An energetic antiseptic with comparatively little poisonous action; inhibits fermentation; used chiefi y in rheuma tism, the free acid acting more powerfully than its salts (e. g. sodium salicylate) but more liable to cause gastric irritation. Dose (in rheu matism) 0.6 to 1.3 Grm. (10 to 20 grs.) four to six times a day. b. Ammonium Salicylate. Properties of Salicylic Acid with some stimulating action. Dose, 0.3 to 1.3 Grm. (5 to 20 grs.). c. Lithium Salicylate. Combines the3

AMYL NITRITE
   Antispasmodic, reducing arterial tension and so causing momen tary acceleration of the heart beat. Used chiefly by inhalation to relax spasm, notably in asthma, in whooping cough. in spasmodic croup, in epileptic seizures, in tetanus and strychnine poisoning and in spasmodic dysmenorrhea. It is a valuable agent also in angina pec toris and in sudden heart failure, but must be used always intelli gently and with due caution remembering that it is a depressant, not a stimulant. Dose. usually 0.13 3

ETHER (Sulphuric Ether)
   Action resembles that of alcohol, but more transient; cardiac stimulant, general anesthetic. relaxant. Most commonly given by inhalation. A spray is sometimes used to produce local anesthesia by cold. Dose, 2 to 8 c. c. (30 Ill to 2 fluidrachms) or more.3

ETHYL CHLORIDE (Kelene)
   An exceedingly volatile liquid, used sometimes by inhalation to produce transient general anesthesia, more frequently in form of a spray to produce local anesthesia by freezing.3

EUCALYPTUSEUAN12
   The leaves of EUCALYPTUS GLOBULUS, Labili. Stimulant tonic, antiseptic, antiperiodic, stomachic. Valuable in treatment of chronic catarrhal affections of the genito-urinary tract and of the air passages. Locally applied as a disinfectant and vulnerary in treat ing foul ulcers, etc. The oflicial volatile oil is the chief active consti tuent, and of this Euealyptol is the valuable portion. Both are used. especially in spray or by inhalation, in subacute and chronic bronchitis; also internally in d3

SACCHARIN (Glusldum)
   A derivative of toluene, remarkable for its intense sweetness. It inhibits partially the action of digestive enzymes, but is used chiefly as a substitute for sugar where that article is inadmissible.3


WARNING: All medicines, drugs, plants, chemicals or medicial precedures below are for historical reference only. Many of these treatments are now known to be harmful and possibly fatal. Do not consume any plant, chemical, drug or otherwise without first consulting a licensed physician that practices medine in the appropriate field.

Physician's Therapeutics Memoranda on Inh

ACIDITY OF STOMACH
   If due to fermentation, use antacids as palliatives to relieve im mediate distress, but prescribe also gastric antiseptics. Avoid indigestible food, particularly lats. If acidity is irom hyper-secretion, the remedies are antacids and henbane, for its inhibitive action on the secretions. In chronic gastric catarrh, bismuth. silver nitrate, antacids combined with salines. In all severe cases. lavage is the most useful treatment.3

ANGINA PECTORIS
   ...ith avoidance of all forms of excitement or violent exertion; cardiac tonics, arsenic or as an alterative phosphorus. During at tack, amyl nitrite by inhalation, nitroglycerin in solution or hypoder matically; for more prolonged action, sodium nitrite. If blood pre - sure is not high, in place of th......nts, Elixir Digitalin Compound, N., B. & Co. or compound spirit ether. Other remedies of value are antipyrin, injections of morphine and atropine and inhalations of oxygen.3

ASTHMA
   For immediate relief, the smoke from mixtures of stramonium or henbane leaves with nitre and a... / ...rphine (used with due caution); in selected cases, amyl nitrite or nitroglyce rin. Sometimes strong coffee will relieve; antipyrin may give relief or inhalations of oxygen; if of nasal origin application to nasal mu cous membrane of a six per cent. solution of cocaine hydrochloride, See that all hyg... / ...of residence.3

BRONCHITIS
   ...e tea or other hot infusion), yconite if required for fever, application to chest of Phenol Camphor; ipecac and potassium salts to promote secretion; inhalations of steam or of moisture-laden air. Later adapt remedies to condition of patient. As expectorants use ammonium chloride, ammonium carbonate......ay excessive cough. As case progresses, use terpin hydrate or terebene, oil oi sandalwood, eucalyptol and similar remedies. Eucalyptol in spray or by inhalation is very eflicient. When there is hypersecretion, avoid ammonium chloride and use belladonna, strychnine and counter-irritation.3

CALCULI, BILIARY
   Relieve pain by hypodermatic injection of morphine and atropine and by cautious inhalations of chloroform, 20 to 30 minims at a... / Relieve pain by hypodermatic injection of morphine and atropine and by cautious inhalations of chloroform, 20 to 30 minims at a time. Give olive oil (not less than half a pint, to which 30 to 60 minims of ether may be added). Trea... / ...mineral waters, effervesciug granules Vichy, oil turpentine internally.3

CONVULSIONS
   ... chloral are the most important remedies, aromatic castor oil being often more useful than any sedative. For adults chloral, or chloroform cautiously inhaled. If hysterical in character, valerian and similar agents. In Puerperal Convulsions, the first indication is to eliminate poisons from the syst......tion if the case demands; Tonic Pilocarpine Compound as a diuretic, or submammary injection of normal salt solution. Control convul sions by cautious inhalations of chloroform, aided by chloral hydrate and potassium bromide. Morphine may be useful, or amyl nitrite. If convulsions complicate labor, d...3

CORYZA
   Treat early stage as in acute bronchitis. The local congestion may be relieved by application of a 4 per cent. solution of cocaine, or a solution of suprarenal extract. Spray or vapor of camphor and menthol or use by inhaler of a little Phenol Camphor gives much relief. Alkal-Antiseptine with nasal douche is a useful remedy.3

LARYNGITIS
   General treatment the same as in acute bronchitis or coryza, As special remedies, inhalations of steam from water to which has been added compound tincture benzoin or Antiseptine or in later stages eucalyptol (a few drops) or menthol, or these latter may be mixed with albolene and used in spray. As local application, at first Glyceroplasma or Phenol Camphor (a few drops several times a day), later oil turpentine or tincture iodine as counter-irritant.3

PERTUSSIS
   Of the numerous remedies prescribed in whooping cough, those which have given best satisfaction are; Bromoform (conveniently in form of Bromofonn Bronchial... / ...or with formaldehyde vapor is the most effective remedy, although not always practicable. In severe paroxysms, a little chloroform or amyl nitrite by inhalation gives relief.3

TETANUS
   Tetanus antitoxin should be administered at once, and convul sions combated by inhalations of chloroform or by chloral combined with potassium bromide (see Bromanodyne, Part I). Other remedies are cocaine or a combination of this with morphine and atropine, hypodermatically; Fowler’s solution; calabar bean; pilocarpine (the last to eliminate the toxin).3

UREMIA
   Promote elimination by skin and bowels; Tonic Pilocarpine Com pound, N., B. & Co. with the hot pack for the former; elaterium for the latter. For convulsions, chloral and bromides (Bromanodyne) or chloroform (by inhalation). Vt!ut3S€3Ctl()n must be considered, with the alternative of intravenous injection of normal salt solution.3


References

1) Bergner, Pal., Griswold, Alexandra F., Hufford, David J., et al. . Morton Grove, Il: Publications International, 2017.
2) Felter, Harvey Wickes, 1922, The Eclectic Materia Medica, Pharmacology and Therapeutics, Cincinnati, Ohio.
3) Nelson, Baker & Co., 1904, Physician's Handy Book of Materia Medica and Therapeustics, Detroit, Michigan.